AstraZeneca (AZN)

Up
Share Price:
13,960.00p
Market Cap:
£216,527m
Change Today:
908.00p
Sector:
Pharma and Biotech

Latest ShareCast News

Astrazeneca posts strong YTD beat, reiterates FY26 guidance

By Iain Gilbert

Date: Friday 30 Oct 2026

(Sharecast News) - Drugmaker Astrazeneca posted another solid earnings beat on Thursday, with year-to-date revenue and profits both rising and core earnings per share up 14%, alongside a further step‑up in late‑stage pipeline momentum.

Astrazeneca's Enhertu secures EU approval

By Iain Gilbert

Date: Tuesday 27 Oct 2026

(Sharecast News) - Drugmaker Astrazeneca said on Tuesday that Enhertu has been approved in the European Union as an adjuvant treatment for adults with HER2‑positive early breast cancer who still have signs of invasive disease after initial chemotherapy and targeted therapy.

Astrazeneca's Ultomiris wins accelerated US approval

By Iain Gilbert

Date: Thursday 22 Oct 2026

(Sharecast News) - Drugmaker Astrazeneca's rare‑disease unit Alexion said on Thursday that Ultomiris had won accelerated US approval as the first treatment aimed at reducing protein levels in the urine of adults with primary IgA nephropathy.

AstraZeneca enters into strategic drug discovery... 15-Oct-2026
AstraZeneca to invest $2bn in Summit Therapeutics 29-Sep-2026
Astrazeneca's Trixeo Aerosphere secures EU appro... 23-Sep-2026
Astrazeneca secures two positive regulatory opin... 21-Sep-2026
Director dealings: Astrazeneca CEO raises stake 18-Sep-2026
Deutsche Bank upgrades Astrazeneca to 'hold' 15-Sep-2026
Astrazeneca's Etcamah trial fails to meet primar... 14-Sep-2026
AstraZeneca sees positive results from lung canc... 08-Sep-2026
AstraZeneca's breast cancer drug granted acceler... 07-Sep-2026
AstraZeneca lifts lung‑cancer pipeline wit... 01-Sep-2026
Astrazeneca's Tezspire delivers positive results... 27-Aug-2026
AstraZeneca posts mixed lung‑cancer trial ... 17-Aug-2026
AstraZeneca, Bristol Myers Squibb in talks over ... 03-Aug-2026
AstraZeneca reports first-half growth, disappoin... 27-Jul-2026
AstraZeneca breast cancer drug receives EU appro... 23-Jul-2026
Astrazeneca strikes exclusive licensing deal wit... 14-Jul-2026
AstraZeneca shares slide on failure of cardiomyo... 09-Jul-2026
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AstraZeneca Market Data

Currency UK Pounds
Price 13,960.00p
Change Today 908.00p
52 Week High 15,316.00p
52 Week Low 11,460.00p
Volume 4,546,444
Shares Issued 1,551.05m
Market Cap £216,527m

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. empty market
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. empty sector
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Price Trend
market
  1. full market star
  2. full market star
  3. full market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. half sector star
  5. empty sector
Income
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Growth
market
  1. full market star
  2. full market star
  3. full market star
  4. full market star
  5. half market star
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. empty sector
Price Chg 6m
market
  1. full market star
  2. full market star
  3. full market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. half sector star
  5. empty sector
P/E
market
  1. full market star
  2. full market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
PEG
market
  1. half market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. half sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Dividend Yield
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
EPS Growth
market
  1. full market star
  2. full market star
  3. full market star
  4. half market star
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. half sector star
Operating Margin
market
  1. full market star
  2. full market star
  3. full market star
  4. half market star
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. half sector star

What The Brokers Say

Strong Buy 10
Buy 8
Neutral 5
Sell 0
Strong Sell 0
Total 23
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.